To review patents of pharmaceutical products
— Pharmaceutical regulatory affairs, India
To confirm when patents for key drugs expire in Australia
— Non-profit, Australia
For information on patent expirations
— Business development manager, Greece
To gain a view for a new molecules with high market potential
— Strategic business development manager, Poland
For information on products (NDAs and ANDAs) that I may be interested in developing, licensing or acquiring
— Executive, specialty pharmaceutical company, USA
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
Copyright 2002-2017 thinkBiotech LLC ISSN: 2162-2639
► Plans and Pricing
Join the 21,151 other biopharma execs who get our Drug Patent Expiration Alerts: